T. Inoue et al., DISPENSABILITY OF P53 DEGRADATION FOR TUMORIGENICITY AND DECREASED SERUM REQUIREMENT OF HUMAN PAPILLOMAVIRUS TYPE-16E6, Molecular carcinogenesis, 21(3), 1998, pp. 215-222
Certain types of human papillomavirus (HPV), such as types 16 and 18,
are etiological agents for carcinogenesis of the uterine cervix. These
HPVs have two oncogenes, E6 and E7, that have transforming activities
in established murine cells. Tumorigenicity and decreased serum requi
rement for cell growth are conferred by the E6 gene, whereas anchorage
-independent growth is mainly governed by the E7 gene. To understand t
he mechanism of cellular transformation by the HPV16 E6 gene, we exami
ned three mutant E6 proteins defective for p53 binding, p53 degradatio
n, or transactivation of the adenovirus E2 promoter for the ability to
induce tumorigenicity and decreased serum requirement. The results sh
owed that tumorigenicity and decreased serum requirement were associat
ed with the ability of E6 to bind to p53, although the subsequent degr
adation of p53 was not required for these functions. (C) 1998 Wiley-Li
ss, Inc.